Detection of mutations from liquid biopsies - applications in cancer diagnostics
Presented By: Monika Seidel
Speaker Biography: Monika Seidel is the scientific lead on new product development from conception throughout feasibility to manufacturing handover. She has extensive knowledge of liquid biopsy-based diagnostic applications including explain ddPCR (ddPCR) and NGS and expertise in molecular biology, biochemistry, immunology-related techniques, mass spectrometry and stem cell biology. Monika’s research has focused on dissecting molecular mechanisms of human diseases in the field of genomics, proteomics and lipidomics including explain iPSc based(iPSc) modelling of motor neuron degeneration, structure function relationship studies in Ryanodine Receptor 2 associated with sudden cardiac death and siRNA-based high content and high throughput screening for identification of molecular targets and signaling pathways of anti-cancer drugs. She has an M.Sc. degree in Biotechnology, B.Sc. in Organic Chemistry and holds a PhD in Medical Sciences from the University of Cardiff, UK.
Webinar: Detection of mutations from liquid biopsies - applications in cancer diagnostics
Webinar Abstract: Cell-free DNA (cfDNA) is currently trending as a biomarker from liquid biopsy in several clinical applications, including oncology, organ and transplant medicine, and non-invasive prenatal testing (NIPT). Although considerably less invasive than tissue biopsy, due to the small amount of cfDNA found in circulation, there is a need to use efficient, highly sensitive extraction protocols coupled with robust and reliable technologies, such as next-generation sequencing (NGS) to detect these mutations.
Join our webinar hosted by Monika Seidel (PhD) to discuss the results of a study using Cytiva’s magnetic silica bead-based Sera-Xtracta™ Cell-Free DNA extraction kit* and targeted NGS for cancer biomarker detection in advanced non-small cell lung cancer (NSCLC) patient samples. The study demonstrates performance in a clinically relevant scenario where patient samples are analyzed for therapy stratification
Видео Detection of mutations from liquid biopsies - applications in cancer diagnostics канала Labroots
Speaker Biography: Monika Seidel is the scientific lead on new product development from conception throughout feasibility to manufacturing handover. She has extensive knowledge of liquid biopsy-based diagnostic applications including explain ddPCR (ddPCR) and NGS and expertise in molecular biology, biochemistry, immunology-related techniques, mass spectrometry and stem cell biology. Monika’s research has focused on dissecting molecular mechanisms of human diseases in the field of genomics, proteomics and lipidomics including explain iPSc based(iPSc) modelling of motor neuron degeneration, structure function relationship studies in Ryanodine Receptor 2 associated with sudden cardiac death and siRNA-based high content and high throughput screening for identification of molecular targets and signaling pathways of anti-cancer drugs. She has an M.Sc. degree in Biotechnology, B.Sc. in Organic Chemistry and holds a PhD in Medical Sciences from the University of Cardiff, UK.
Webinar: Detection of mutations from liquid biopsies - applications in cancer diagnostics
Webinar Abstract: Cell-free DNA (cfDNA) is currently trending as a biomarker from liquid biopsy in several clinical applications, including oncology, organ and transplant medicine, and non-invasive prenatal testing (NIPT). Although considerably less invasive than tissue biopsy, due to the small amount of cfDNA found in circulation, there is a need to use efficient, highly sensitive extraction protocols coupled with robust and reliable technologies, such as next-generation sequencing (NGS) to detect these mutations.
Join our webinar hosted by Monika Seidel (PhD) to discuss the results of a study using Cytiva’s magnetic silica bead-based Sera-Xtracta™ Cell-Free DNA extraction kit* and targeted NGS for cancer biomarker detection in advanced non-small cell lung cancer (NSCLC) patient samples. The study demonstrates performance in a clinically relevant scenario where patient samples are analyzed for therapy stratification
Видео Detection of mutations from liquid biopsies - applications in cancer diagnostics канала Labroots
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
How Liquid Biopsy Can Revolutionise Medical Diagnostics | Dennis LoTRACO 2018 - Non-small cell lung cancer and GenomicsWebinar: The Promise of Liquid Biopsy for Individualizing Cancer CareAntibody Purification Webinar: What you need to know to use antibodies effectivelyDrew Berry: Animations of unseeable biologyScottsdale doctor gives insight on cancer caused by textured implantsCurrent Trends in Cancer Research: Cancer Genomes, Genetic Tools and ImmunotherapyLiquid Biopsy - Tumoren mittels Blutprobe auf der SpurMicroRNAs in Inflammation and CancerLeukemia diagnosis | Hematologic System Diseases | NCLEX-RN | Khan AcademyInterpreting Genomes for Rare Disease: Intro to Next Generation Sequencing - Daniel MacArthur, PhDLiquid biopsy in daily clinical practiceA digital PCR-based protocol to detect and quantify RNA editing events at hotspotsHistory of digital PCR: (r)evolution in genetic testing & analysisUsing Droplet Digital™ PCR for Cancer and Liquid Biopsy StudiesAutomated sample preparation for reproducible clinical proteomicsBite Size Science: Diabetes and DementiaBiomarker Discovery, Quantitation, and Analysis with Multiplex ImmunoassaysFinding Somatic Mutations in Cancer Genome Sequence DataStanford Radiology: CEDSS (Spring) 2020, Fung: Early cancer detection using plasma cfDNA